coin-img-BTCBTC-1.14%coin-img-ETHETH+0.05%coin-img-SOLSOL-0.62%coin-img-XRPXRP-1.54%coin-img-USDCUSDC+0.00%coin-img-LABLAB-20.62%coin-img-TRXTRX+0.42%coin-img-HYPEHYPE-0.40%coin-img-BTCBTC-1.14%coin-img-ETHETH+0.05%coin-img-SOLSOL-0.62%coin-img-XRPXRP-1.54%coin-img-USDCUSDC+0.00%coin-img-LABLAB-20.62%coin-img-TRXTRX+0.42%coin-img-HYPEHYPE-0.40%coin-img-BTCBTC-1.14%coin-img-ETHETH+0.05%coin-img-SOLSOL-0.62%coin-img-XRPXRP-1.54%coin-img-USDCUSDC+0.00%coin-img-LABLAB-20.62%coin-img-TRXTRX+0.42%coin-img-HYPEHYPE-0.40%coin-img-BTCBTC-1.14%coin-img-ETHETH+0.05%coin-img-SOLSOL-0.62%coin-img-XRPXRP-1.54%coin-img-USDCUSDC+0.00%coin-img-LABLAB-20.62%coin-img-TRXTRX+0.42%coin-img-HYPEHYPE-0.40%

MeCure Industries seeks N50bn raise as 2025 profit jumps 177%

AI Market Summary
Nigeria-listed pharmaceutical company MeCure Industries reported strong FY2025 results (revenue +69%, EBIT +98%, net profit +177%) and shareholder approval for a 32 kobo dividend and an expanded capital-raise plan to 50bn naira via rights issue. Regulatory approval for 19 new products and entry into Sierra Leone signal growth momentum, but the news is largely idiosyncratic and not broadly market-moving.
Impact level
● Low
Affected assets
NCCOGOLD2USD/USDT-1.02%
AI Insight · NCCOGOLD2USD/USDTAI Insight
● Neutral
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
MeCure Industries reported 2025 results showing revenue of N77.69 billion, up 69%, with EBIT of N16.43 billion, up 98%, and profit after tax of N6.46 billion, up 177%. The company said it secured approvals for 19 new medicines and expanded into Sierra Leone. Shareholders approved a dividend of 32 kobo per share and agreed to increase the company’s capital-raising plan to N50 billion from N30 billion.
Disclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.
Stocks

Risk Warning

Cryptocurrencies and their derivatives are innovative financial products with great volatility and high investment risks.

Although BingX is committed to providing users with easy-to-use trading tools, trading itself is still a highly sophisticated field. Trading digital assets and their derivatives are subject to high market risk and price volatility and may result in partial or total loss of account funds. You must carefully consider and exercise clear judgment to evaluate your financial situation and the aforementioned risks before using BingX Services. You shall be responsible for all losses arising therefrom. If necessary, please consult relevant professionals to make informed decisions before investing. By accessing, downloading, using or clicking on "I agree" to accept any BingX Services provided by BingX, you agree that you have read, understood and accepted all of the terms and conditions stipulated in BingX Terms of Use as well as our Privacy Policy.


Trading by copying or replicating the trades of other traders involves a high level of risks, even when copying or replicating the top-performing traders. Past performance of a BingX community member is not a reliable indicator of his future performance. Content on BingX's trading platform is generated by members of its community and does not contain advice or recommendations by or on behalf of BingX.